Glaucoma Surgery Devices Market By Product Type (Glaucoma drainage device {Valves, Glaucoma drainage implant, Glaucoma tube shunts, Stents}, Traditional Surgery Devices {Scalpel, Forceps, Ophthalmic scissors, Punch, Sutures, Surgical drapes, Microcatheter, Others}, Diamond knives {Laser systems, Others}), By Surgery Method (Traditional Glaucoma Surgery {Trabeculectomy, Tube Shunt Surgery}, Minimal Invasive Glaucoma Surgery {Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endo cyclophotocoagulation}, Laser Surgery {Trabeculoplasty, Iridotomy, Cyclophotocoagulation}), By End-User (Hospitals, Ophthalmic clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Glaucoma Surgery Devices market accounted for USD 2.05 Billion in 2024 and is expected to reach USD 4.45 Billion by 2035, growing at a CAGR of around 7.3% between 2025 and 2035.  Glaucoma Surgery Devices Market refers to tools and equipment used in surgery to address glaucoma, a disease involving damage to the optic nerve due to raised intraocular pressure. These micro stents, drainage implants, and lasers, along with surgical tools help to alleviate the pressure imposed on the vision of the afflicted eye. The demand for these devices is driven by the increasing prevalence of glaucoma, the growing aging of the population, and the recent progress in minimally invasive glaucoma surgery (MIGS). Technologies that offer better stent designs and laser procedures are thus contributing to better treatment outcomes. The Glaucoma Surgery Devices Market has witnessed greater adoption in hospitals and eye care centers.

Report Scope:

Market Dynamics

The rise in global glaucoma incidence, especially among older adults, is driving the demand for advanced surgical interventions.

The Glaucoma Surgery Devices Market is experiencing a surge in demand because of the rising incidence of glaucoma worldwide, which typically affects the elderly. These devices provide sophisticated surgical procedures. Since the population is growing, people are becoming more vulnerable to this illness, and halting its progression requires early detection and treatment. Age-related changes in the eye act as a major risk factor, making the older population more vulnerable to glaucoma. As per the World Health Organization (WHO), glaucoma is the cause of visual impairment in 64.3 million people worldwide, and the number is anticipated to reach 76 million by the year 2020. The massive disease burden being experienced due to the increase in glaucoma cases has resulted in the utilization of advanced surgical techniques, such as minimally invasive glaucoma surgeries, which in turn have raised the demand for specific devices. As the population continues to change, there will likely be a greater need for innovative technologies that increase accuracy, shorten recovery times, and improve cases.

Micro-invasive surgeries reduce recovery time, driving surgical device adoption.

Micro-invasive surgeries (MIGS) are key drivers for the Glaucoma Surgery Devices Market due to their capacity for reduced recovery times and improved patient outcomes. MIGS surgeries are performed only in small incision areas, and they damage very few tissues. In most cases, surgery is followed by a shorter recovery period than in the case of traditional glaucoma surgeries.

More than 3 million Americans suffer from glaucoma, according to data from the National Eye Institute (NEI), and the trend toward minimally invasive procedures is a reaction to the need for less traumatic therapies. MIGS offers simpler advantages, and the patient recovers in a shorter amount of time.

Surgical risks and complications deter patients from choosing surgery.

Surgical risks and complications serve as a major obstacle to the Glaucoma Surgery Devices Market. Glaucoma surgeries are often necessary to prevent sight loss, but they come with potential risks such as infection, bleeding, and damage to surrounding eye structures. These risks may be related to the pain, which has prolonged periods of recovery and in some cases can trigger the symptoms' aggravation. As a result, patients may be more likely to choose non-invasive procedures that are typically seen to be safer, such as eye drops and laser therapy, over surgical procedures. Furthermore, because of the lack of highly qualified surgeons and high-quality facilities, patients may be reluctant to have surgery if they are unfamiliar with the difficulties that may arise after the procedure, particularly in impoverished rural areas. Doubtless, this hesitation leads to slower adoption of the most advanced glaucoma surgery devices, thus causing the market to experience a slump in growth.

AI and robotic integration improve precision and surgical outcomes.

AI and robotic integration in the Glaucoma Surgery Devices Market has a significant potential for the improvement of precision in the surgery and consequent outcomes for the patient. Better accuracy in identifying and treating glaucoma is achieved with the application of artificial intelligence in robotic systems during surgeries and diagnostic instruments. Artificial intelligence (AI) can analyse large datasets, uncover hidden patterns, and help surgeons make better decisions during procedures, reducing human error. The robotic system enables better control and stability during surgery, which enables more precise incisions and less tissue damage. Robotic technologies provide a surgeon with high-quality control and stability to ensure operation with the least tissue damage.

3D-printed surgical tools can reduce costs and enhance precision.

3D-printed surgical tools offer a promising opportunity for the Glaucoma Surgery Devices Market by reducing costs and enhancing precision. Patient-specific surgical instruments would be designed with the help of 3D printing technology in such high-precision surgeries for glaucoma patients and thus would make the process relatively more efficient. Such devices can be made by modelling the eye of the patient and designing the instruments to be precisely the same, which guarantees a better operation and minimizes the risks of complications. Furthermore, the ability to rapidly develop and produce high-quality, reasonably priced surgical instruments will undoubtedly lead to a greater use of this technology in glaucoma surgery and, consequently, significant market expansion. The use of 3D-printed tools also supports the trend toward minimally invasive surgery, which patients are favouring, which in turn fuels the demand for increasingly advanced surgical tools.

Industry Experts Opinion

“The introduction of micro-invasive glaucoma surgery (MIGS) devices, especially, has resulted in the opening up of the market to a new group of surgeons, with cataract surgeons now performing combination procedures.”

• Ms Kristen Harmon Ingenito, vice president of Market Scope in St Louis

"We believe that OMNI uniquely enables clinicians to address all three primary points of resistance in the eye’s diseased conventional outflow pathway with a single device, through a single microincision. These results support its long-term benefits and potential for expanded indications in other glaucoma patient populations."

• Paul Badawi, co-founder and CEO of Sight Sciences

Segment Analysis

Based on the product type, the Glaucoma Surgery Devices Market has been classified into Glaucoma drainage devices, Traditional Surgery Devices, and Diamond knives. The Glaucoma drainage devices market segment is the most prominent and significant in the Glaucoma Surgery Devices Market. These include valves, implants, tube shunts, and stents. These are frequently used to treat glaucoma sufferers' intraocular pressure. These have become an important component because they prevent further loss of vision by maintaining the appropriate drainage of fluid from the eye. This trend, along with the development of minimally invasive surgeries, contributes to the strengthening of the segment. Besides, an enhancement of drainage technology has made these devices more reliable and accessible for patients.

Based on the Surgery Method, the Glaucoma Surgery Devices Market has been classified into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. In the Glaucoma Surgery Devices Market, Minimal Invasive Glaucoma Surgery (MIGS) is the most significant and dominating category. Techniques like MIGS via trabecular meshwork bypass and suprachoroidal space implants have become more prominent in that they can offer substantial pressure control with fewer complications than traditional methods and faster recovery. Better patient outcomes and quicker recovery periods than phacoemulsification are the primary reasons MIGS has gained popularity among patients and professionals. Advances in the engineering of surgical devices that focus specifically on these MIGS procedures provide further impetus for this trend.

Regional Analysis

The North American Glaucoma Surgery Devices Market is growing rapidly and is primarily led by the United States, which has the highest share of the Glaucoma Surgery Devices Market. The base of the elderly population, coupled with high glaucoma prevalence in this population and advanced healthcare infrastructure, is the basis of growth in the region. Substantial research and development investments, combined with innovative minimally invasive surgical devices, further propel the market forward. Growth is being aided by the increased presence of key players and government campaigns to increase public knowledge of glaucoma and improve treatment. The glaucoma surgical devices market is being impacted by patient awareness of the need to receive the proper diagnosis and treatments on time.

The United States Glaucoma Surgery Devices Market is driven by a large aging population and high prevalence of glaucoma. The well-developed healthcare infrastructure coupled with high-end diagnostic and surgical technologies supports the wide-scale adoption of glaucoma surgeries. The U.S. Glaucoma Surgery Devices Market has a well-established reimbursement system that makes advanced treatments available to the population. Growth in the market due to increased demand for less invasive surgeries, such as micro-incision and laser-based procedures, is being witnessed. Government initiatives, along with public awareness programs, have boosted public awareness of glaucoma as a more serious eye disorder. Strong research and development activities by the major medical device companies further reinforce the directions of innovation for products in the field of glaucoma surgery devices. All these factors keep the United States up to date with market expansion; a healthy investment in healthcare and a favourable regulatory environment will keep on driving the U.S. moving forward.

The European Glaucoma Surgery Devices Market is experiencing significant growth due to the increasing elderly population and the high awareness of the disease. Germany, France, the UK, and Italy are some of the countries with well-developed healthcare systems, but their overall adoption of the newest technological practices in surgery is rather average. The demand for MIGS and laser procedures is growing due to patients spending less time in hospitals for recovery from these minimally invasive procedures. Strengthened healthcare infrastructure for the country in Europe combined with government-funded programs assures wide accessibility to treatments for glaucoma. Also, the market is sustained by continuous technological advancements and key industry players. Research funding, along with collaborations between academic institutions as well as medical device manufacturers, adds to the development of innovative solutions.

Germany's Glaucoma Surgery Devices Market has the largest market share in the whole of Europe, due to its developed healthcare infrastructure and a large number of elderly people who are susceptible to glaucoma infections. The country's long-established healthcare system guarantees easy access to medical treatment for all citizens, with reimbursement policies that encompass the most sophisticated surgical procedures. The growing preference for minimally invasive surgeries, such as MIGS, is gaining popularity because of their shorter recovery times and effectiveness. Furthermore, Germany is also a hotspot for new medical inventions, where there is a high rate of research and development in the treatment of glaucoma. The country enjoys the advantage of a strong regulatory environment and a high level of awareness about managing glaucoma. The country is likely to continue to grow steadily in the glaucoma surgery device market. However, with the introduction of cutting-edge technologies, it will manage to thrive even further.

Competitive Landscape

The competitive landscape of the Glaucoma Surgery Devices Market is dominated by both established global players and specialized ophthalmic firms. Alcon, Glaukos, and Johnson & Johnson Vision are among the companies that are mastering the use of advanced tools such as microstates and minimally invasive glaucoma surgery (MIGS) devices.

The companies are concentrating on safer and more efficient surgical procedures. The primary strategies include strategic alliances and acquisitions, such as AbbVie's acquisition of Allergan to expand its product line. North America and Europe are the leading markets, while Asia-Pacific is a region that is seeing a rise in healthcare investments. Regulatory approvals are of the essence to the market's growth.

Glaucoma Surgery Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• July 2024: Alcon acquired Belkin Vision, gaining access to a new laser treatment for glaucoma and planning to introduce this technology to the U.S. market.
• February 2024: Glaukos launched the iDose TR (travoprost intracameral implant), designed to reduce intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
• August 2023: Nova Eye Medical reported strong sales following the U.S. launch of its iTrack Advance glaucoma surgical device, a consumable tool with an illuminated fiber optic tip aimed at enhancing canaloplasty surgery for treating glaucoma.

Report Coverage:

By Product Type

• Glaucoma drainage device
  • Valves
  • Glaucoma drainage implant
  • Glaucoma tube shunts
  • Stents
• Traditional Surgery Devices
  • Scalpel
  • Forceps
  • Ophthalmic scissors
  • Punch
  • Sutures
  • Surgical drapes
  • Microcatheter
  • Others
• Diamond knives
  • Laser systems
  • Others

By Surgery Method

• Traditional Glaucoma Surgery
  • Trabeculectomy
  • Tube Shunt Surgery
• Minimal Invasive Glaucoma Surgery
  • Trabecular Meshwork Bypass
  • Suprachoroidal Space Implants
  • Subconjunctival Space Implants
  • Schlemm’s Canal Implants
  • Gonioscopy-assisted Transluminal Trabeculectomy
  • Endocyclophotocoagulation
• Laser Surgery
  • Trabeculoplasty
  • Iridotomy
  • Cyclophotocoagulation

By End-User

• Hospitals
• Ophthalmic clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Alcon Inc.
• Glaukos Corporation
• Johnson & Johnson Vision
• New World Medical
• Sight Sciences
• Santen Pharmaceutical Co., Ltd.
• Bausch + Lomb
• Carl Zeiss Meditec
• Lumenis Be Ltd.
• Topcon Corporation
• Allergan
• Ellex Medical Lasers
• Nova Eye Medical
• Ziemer Ophthalmic Systems
• ASICO LLC
• Katalyst Surgical LLC

Frequently Asked Questions (FAQs)